HCA Healthcare, Inc.
HCA- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- SEC CIK
- 0000860730
No open-market purchases or sales by HCA Healthcare, Inc. insiders were filed in the last 90 days; 1,343 institutions reported holding it in 13F filings for Q2 2026, worth $52.5B in total; superinvestors Harris Associates (Oakmark) and Markel Group hold it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −64 vs. previous quarter
- 1,343
- 13F valueReported value at the end of Q2 2026
- $52.5B
- Superinvestors holdingAt the end of Q2 2026
- 2
Price chart
Superinvestors holding HCA, Q2 2026
2 superinvestors report holding HCA Healthcare, Inc. on Form 13F. Percentages are the stock's share of each portfolio.
Harris Associates (Oakmark)
Bill Nygren
0.1%
HCA Healthcare, Inc.'s share of the portfolio
- Shares
- 154,097
- Value
- $60.1M
Latest insider trades
Open-market purchases and sales by HCA Healthcare, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 (view filing) | Feb 18 | Same day | McAlevey Michael REVP & Chief Legal & Admin Off. | SSale | −1.69K | $533.37 | −$903.5K | −16.1%8.85K after | |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Wyatt Christopher F.SVP & Controller | SSale | −4.00K | $505.00 | −$2.02M | −8.3%44.4K after | |
| Feb 12, 2026 (view filing) | Feb 11 | 1 day | Berres JenniferSVP & Chief Human Res. Officer | SSale | −8.02K | $514.58 | −$4.13M | −40.1%12.0K after | 2 lots |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Hazen Samuel NCEO | SSale | −42.9K | $501.04 | −$21.5M | −57.1%32.3K after | 7 lots |
| Feb 5, 2026 (view filing) | Feb 3 | 2 days | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −1.50K | $498.09 | −$747.1K | −4.8%30.0K after | |
| Nov 5, 2025 (view filing) | Nov 5 | Same day | McAlevey Michael REVP & Chief Legal & Admin Off. | SSale | −3.89K | $473.79 | −$1.84M | −52.7%3.49K after | |
| Sep 8, 2025 (view filing) | Sep 8 | Same day | Cuffe Michael S.EVP and Chief Clinical Officer | SSale | −3.84K | $418.84 | −$1.61M | −10.9%31.5K after | 10b5-1 |
| May 15, 2025 (view filing) | May 13 | 2 days | Foster Jon MEVP and COO | SSale | −15.7K | $369.32 | −$5.80M | −55.4%12.6K after | |
| Mar 28, 2025 (view filing)4:11 PM ET | Jul 26, 2011-Mar 19, 2012 | 4,994 daysLate | Bank Of America Corp and 2 others10% Owner | PPurchase | +3.44K | $25.67 | +$88.2K | New position0 after | 13 lots |
| Mar 28, 2025 (view filing)4:11 PM ET | Jan 10-Apr 3, 2012 | 4,826 daysLate | Bank Of America Corp and 2 others10% Owner | SSale | −3.18K | $25.12 | −$79.8K | −100.0%0 after | 17 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in HCA Healthcare, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,003,600 | $5.07B | 0.08% | −359,666−2.7% | Reduced |
| Vanguard Capital Management LLC | 10,141,708 | $3.95B | 0.08% | −36,654−0.4% | Reduced |
| Sanders Capital, LLC | 8,828,287 | $3.44B | 3.45% | −128,858−1.4% | Reduced |
| State Street Corp | 7,469,035 | $2.91B | 0.09% | −70,515−0.9% | Reduced |
| First Eagle Investment Management, LLC | 6,591,130 | $2.57B | 2.13% | +3,336,560+102.5% | Added |
| Wellington Management Group LLP | 4,707,473 | $1.84B | 0.32% | +799,761+20.5% | Added |
| Geode Capital Management, LLC | 3,668,008 | $1.42B | 0.08% | −24,505−0.7% | Reduced |
| Vanguard Portfolio Management LLC | 2,712,828 | $1.06B | 0.05% | −44,951−1.6% | Reduced |
| Morgan Stanley | 2,586,771 | $1.01B | 0.05% | +291,891+12.7% | Added |
| Goldman Sachs Group Inc | 2,464,314 | $960.8M | 0.10% | +328,242+15.4% | Added |